Atreca, Inc. Operating CF/Net income

Operating CF/Net income of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF/Net income growth rates and interactive chart. Calculated as operating cash flow divided by net income to common shareholders. Also called income quality ratio. A ratio of greater than 1.0 usually indicates high-quality income, while a ratio of less than 1.0 indicates low-quality.

Highlights and Quick Summary

  • Operating CF/Net income for the quarter ending September 30, 2022 was 0.71 (a -15.39% decrease compared to previous quarter)
  • Year-over-year quarterly Operating CF/Net income increased by 30.04%
  • Annual Operating CF/Net income for 2021 was 0.56 (a -27.84% decrease from previous year)
  • Annual Operating CF/Net income for 2020 was 0.77 (a -10.98% decrease from previous year)
  • Annual Operating CF/Net income for 2019 was 0.87 (a -5.16% decrease from previous year)
  • Twelve month Operating CF/Net income ending September 30, 2022 was 0.77 (a 4.49% increase compared to previous quarter)
  • Twelve month trailing Operating CF/Net income increased by 38.69% year-over-year
Trailing Operating CF/Net income for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
0.77 0.74 0.63 0.56
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF/Net income of Atreca, Inc.

Most recent Operating CF/Net incomeof BCEL including historical data for past 10 years.

Interactive Chart of Operating CF/Net income of Atreca, Inc.

Atreca, Inc. Operating CF/Net income for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 0.71 0.84 1.03 –
2021 0.55 0.59 0.41 0.69 0.56
2020 0.79 0.65 0.78 0.88 0.77
2019 0.81 0.98 0.77 0.96 0.87
2018 – 0.0 0.79 1.86 0.91
2017 – – – – 0.91

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com